Search by Drug Name or NDC

    NDC 10019-0646-34 SUPRANE 240 mL/240mL Details

    SUPRANE 240 mL/240mL

    SUPRANE is a RESPIRATORY (INHALATION) LIQUID in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is DESFLURANE.

    Product Information

    NDC 10019-0646
    Product ID 10019-646_9519a67c-bd7e-4d62-bf3f-73e7784837e6
    Associated GPIs 70200007002000
    GCN Sequence Number 018738
    GCN Sequence Number Description desflurane LIQUID 100 % INHALATION
    HIC3 H2B
    HIC3 Description GENERAL ANESTHETICS,INHALANT
    GCN 27120
    HICL Sequence Number 007617
    HICL Sequence Number Description DESFLURANE
    Brand/Generic Brand
    Proprietary Name SUPRANE
    Proprietary Name Suffix n/a
    Non-Proprietary Name DESFLURANE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LIQUID
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 240
    Active Ingredient Units mL/240mL
    Substance Name DESFLURANE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class General Anesthesia [PE], General Anesthetic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020118
    Listing Certified Through 2024-12-31

    Package

    NDC 10019-0646-34 (10019064634)

    NDC Package Code 10019-646-34
    Billing NDC 10019064634
    Package 6 BOTTLE in 1 CARTON (10019-646-34) / 240 mL in 1 BOTTLE (10019-646-64)
    Marketing Start Date 1992-09-18
    NDC Exclude Flag N
    Pricing Information N/A